反应详情

5-(2-Adamantan-1-yl-ethyl)-2-pyridine-2-yl-1H-imidazole-4-carboxylic acid (prepared according to the procedure of Example 70, steps a and b, with the modification that pyridine-2-carboxaldehyde was used instead of 2-dimethylamino-benzaldehyde in step a) was reacted with 5-amino-2-methyl-benzoic acid benzyl ester according to the procedure of Example 177, step a to afford 5-{[5-(2-adamantan-1-yl-ethyl)-2-pyridine-2-yl-1H-imidazole-4-carbonyl]-amino}-2-methyl-benzoic acid benzyl ester. The benzyl group was removed following the procedure of Example 1, step e, to afford the title compound as a white solid. 1H NMR (300 MHz, d6-DMSO) 13.18 (1H, br s), 9.71 (1H, br s), 8.66 (1H, d), 8.32 (1H, s), 8.25 (1H, d), 7.96 (1H, td), 7.86 (1H, dd), 7.44 (1H, m), 7.24 (1H, d), 2.98 (2H, m), 2.48 (3H, s),1.94 (3H, br s), 1.63 (6H, m), 1.53 (6H, m), 1.42 (2H, m). The product was converted to the L-tartaric acid salt and lyophilised from water/dioxan. Found: C, 59.07; H, 6.40; N, 8.28%. C33H38N4O8.2.0 mols H2O requires: C, 59.10; H, 6.31; N, 8.35%.